RS58033B1 - Postupci za pripremu naelektrisanih umreživača - Google Patents

Postupci za pripremu naelektrisanih umreživača

Info

Publication number
RS58033B1
RS58033B1 RS20181471A RSP20181471A RS58033B1 RS 58033 B1 RS58033 B1 RS 58033B1 RS 20181471 A RS20181471 A RS 20181471A RS P20181471 A RSP20181471 A RS P20181471A RS 58033 B1 RS58033 B1 RS 58033B1
Authority
RS
Serbia
Prior art keywords
preparation
methods
charged crosslinkers
crosslinkers
charged
Prior art date
Application number
RS20181471A
Other languages
English (en)
Inventor
Wei Li
Robert Zhao
Original Assignee
Immunogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunogen Inc filed Critical Immunogen Inc
Publication of RS58033B1 publication Critical patent/RS58033B1/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • C07D213/71Sulfur atoms to which a second hetero atom is attached
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C305/00Esters of sulfuric acids
    • C07C305/02Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C305/04Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton being acyclic and saturated
    • C07C305/06Hydrogenosulfates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • C07D207/444Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5
    • C07D207/448Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide
    • C07D207/452Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide with hydrocarbon radicals, substituted by hetero atoms, directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/36Sulfur-, selenium-, or tellurium-containing compounds
    • C08K5/37Thiols
    • C08K5/372Sulfides, e.g. R-(S)x-R'
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polyamides (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
RS20181471A 2010-12-09 2011-12-08 Postupci za pripremu naelektrisanih umreživača RS58033B1 (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42135710P 2010-12-09 2010-12-09
EP16186412.9A EP3153504B1 (en) 2010-12-09 2011-12-08 Methods for the preparation of charged crosslinkers

Publications (1)

Publication Number Publication Date
RS58033B1 true RS58033B1 (sr) 2019-02-28

Family

ID=46207513

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20181471A RS58033B1 (sr) 2010-12-09 2011-12-08 Postupci za pripremu naelektrisanih umreživača

Country Status (18)

Country Link
US (5) US8598362B2 (sr)
EP (2) EP2648510B1 (sr)
KR (1) KR101959578B1 (sr)
CN (2) CN103260406B (sr)
CY (1) CY1121055T1 (sr)
DK (1) DK3153504T3 (sr)
ES (2) ES2602118T3 (sr)
HR (1) HRP20182026T1 (sr)
HU (1) HUE041699T2 (sr)
IL (3) IL226795A (sr)
LT (1) LT3153504T (sr)
PL (1) PL3153504T3 (sr)
PT (1) PT3153504T (sr)
RS (1) RS58033B1 (sr)
SG (3) SG10202005580RA (sr)
SI (1) SI3153504T1 (sr)
TR (1) TR201819440T4 (sr)
WO (1) WO2012078868A1 (sr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103260406B (zh) * 2010-12-09 2016-10-19 伊缪诺金公司 制备带电荷交联剂的方法
JP6026305B2 (ja) 2013-02-04 2016-11-16 古河電気工業株式会社 標識抗体の製造方法
WO2014210267A1 (en) 2013-06-28 2014-12-31 Immunogen, Inc. Purification of intermediates used in the preparation of heterobifunctional linkers
US10208125B2 (en) 2013-07-15 2019-02-19 University of Pittsburgh—of the Commonwealth System of Higher Education Anti-mucin 1 binding agents and uses thereof
ES2960619T3 (es) 2014-02-28 2024-03-05 Hangzhou Dac Biotech Co Ltd Enlazadores cargados y sus usos para la conjugación
CN104892748B (zh) * 2014-03-04 2018-12-21 深圳翰宇药业股份有限公司 人类松弛素-2衍生物以及由其制备人类松弛素-2的方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1926422A (en) 1930-12-29 1933-09-12 Fred C Armbruster Pipe joint
DE800410C (de) 1948-10-02 1950-11-06 Basf Ag Verfahren zur Herstellung von Lactonsulfonsaeuren
US2822387A (en) * 1955-12-07 1958-02-04 Universal Oil Prod Co Method of producing sulfonated alkanes
US3418290A (en) * 1965-10-18 1968-12-24 Du Pont Sulfonated caprolactones and polymerization with 2,2-dialkyl-3-propiolactones
US4244885A (en) * 1977-12-08 1981-01-13 Yeda Research And Development Co. Ltd. α-Substituted-3-(halomethyl)-4-hydroxybenzeneacetic acids
US4563304A (en) 1981-02-27 1986-01-07 Pharmacia Fine Chemicals Ab Pyridine compounds modifying proteins, polypeptides or polysaccharides
US5208020A (en) 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
EP0563475B1 (en) 1992-03-25 2000-05-31 Immunogen Inc Cell binding agent conjugates of derivatives of CC-1065
CA2130723C (en) * 1993-09-03 2006-01-31 Wilhelm Quittmann Process for preparing y-mercaptocarboxylic acid derivatives
DE19609338A1 (de) * 1996-03-11 1997-09-18 Hoechst Ag Benzothioxanthen-Farbstoffe, ihre Herstellung und ihre Verwendung
ATE349438T1 (de) 1999-11-24 2007-01-15 Immunogen Inc Cytotoxische wirkstoffe enthaltend taxane und deren therapeutische anwendung
US6716821B2 (en) 2001-12-21 2004-04-06 Immunogen Inc. Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same
US6756397B2 (en) 2002-04-05 2004-06-29 Immunogen, Inc. Prodrugs of CC-1065 analogs
AU2003225305A1 (en) 2002-05-08 2003-11-11 Bristol-Myers Squibb Company Pyridine-based thyroid receptor ligands
AU2003259163B2 (en) * 2002-08-16 2008-07-03 Immunogen, Inc. Cross-linkers with high reactivity and solubility and their use in the preparation of conjugates for targeted delivery of small molecule drugs
US7276497B2 (en) 2003-05-20 2007-10-02 Immunogen Inc. Cytotoxic agents comprising new maytansinoids
EP1688415A1 (en) 2004-12-07 2006-08-09 Aventis Pharma S.A. Cytotoxic agents comprising new C-2 modified taxanes
EP2276506A4 (en) 2008-04-30 2014-05-07 Immunogen Inc EFFICIENT CONJUGATES AND HYDROPHILIC BINDER
US8236319B2 (en) 2008-04-30 2012-08-07 Immunogen, Inc. Cross-linkers and their uses
RU2545080C2 (ru) 2009-02-05 2015-03-27 Иммьюноджен, Инк. Новые производные бензодиазепина
CN103260406B (zh) 2010-12-09 2016-10-19 伊缪诺金公司 制备带电荷交联剂的方法

Also Published As

Publication number Publication date
IL240201A0 (en) 2015-09-24
US20160272616A1 (en) 2016-09-22
IL240200A0 (en) 2015-09-24
EP2648510A4 (en) 2014-05-07
IL226795A (en) 2015-08-31
PT3153504T (pt) 2018-12-27
KR101959578B1 (ko) 2019-03-18
CY1121055T1 (el) 2019-12-11
SI3153504T1 (sl) 2019-03-29
DK3153504T3 (en) 2019-01-07
US20140135502A1 (en) 2014-05-15
US20170327486A1 (en) 2017-11-16
TR201819440T4 (tr) 2019-01-21
SG10201509886YA (en) 2016-01-28
US8598362B2 (en) 2013-12-03
CN103260406A (zh) 2013-08-21
CN107011253A (zh) 2017-08-04
EP3153504A1 (en) 2017-04-12
ES2602118T3 (es) 2017-02-17
CN107011253B (zh) 2021-01-15
ES2702926T3 (es) 2019-03-06
US10112925B2 (en) 2018-10-30
SG10202005580RA (en) 2020-07-29
CN103260406B (zh) 2016-10-19
HUE041699T2 (hu) 2019-05-28
US20120165537A1 (en) 2012-06-28
EP3153504B1 (en) 2018-09-26
WO2012078868A1 (en) 2012-06-14
US9663492B2 (en) 2017-05-30
LT3153504T (lt) 2019-02-11
EP2648510A1 (en) 2013-10-16
PL3153504T3 (pl) 2019-04-30
US8921566B2 (en) 2014-12-30
EP2648510B1 (en) 2016-08-31
US9242936B2 (en) 2016-01-26
IL240200A (en) 2017-02-28
HRP20182026T1 (hr) 2019-02-22
SG190214A1 (en) 2013-06-28
US20150166482A1 (en) 2015-06-18
KR20130124336A (ko) 2013-11-13

Similar Documents

Publication Publication Date Title
HK1253006A1 (zh) 製備截短側耳素的工藝
PT2539136T (pt) Poste de barreira e método de fabrico do mesmo
ZA201305972B (en) Method for the preparation of biphephos
ZA201103820B (en) Process for the preparation of tenofovir
HRP20182026T1 (hr) Postupci za pripremu nabijenih sredstava za umrežavanje
SG11201400939YA (en) Process for the preparation of methoxymelonal
IL226436A0 (en) Methods for the preparation of bendamustine
EP2596007A4 (en) PROCESS FOR THE PREPARATION OF 17-DEOXY-CORTICOSTEROIDS
ZA201300546B (en) Process for the preparation of 3-haloalkylpyrazoles
PT2603319E (pt) Processo para a preparação de uretanos
PT2593423E (pt) Processo para a preparação de agentes de contraste
PL2702045T3 (pl) Nowy sposób sporządzania Etrawiryny
PT2390246T (pt) Processo para a preparação de aminaftona
HUP1000018A2 (en) Process for the preparation of distrontium ranelate
PT2598504E (pt) Novo processo de fabrico de dimiracetam
ZA201209495B (en) Novel methods for the preparation of p2x7r antagonists
IL224304A (en) A process for making dichlorobulben
TWM389392U (en) Structural improvement of charger
GB201019078D0 (en) Process for the preparation of rosuvastatin
GB201012186D0 (en) Methods for the preparation of cellular therapies
IL211422A0 (en) Methods of requcing the power of stsong destzuctive eaztnquakes
PL394420A1 (pl) Sposób wytwarzania dilauroilofluoresceiny
PL394378A1 (pl) Sposób otrzymywania E-2-amino-4-nitrostilbenów
PL391682A1 (pl) Sposób otrzymywania ε-kaprolaktonu